Global Biobanking Market Research Report 2023(Status and Outlook)

Global Biobanking Market Research Report 2023(Status and Outlook)



Report Overview

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

The Global Biobanking Market Size was estimated at USD 2935.00 million in 2022 and is projected to reach USD 4682.22 million by 2029, exhibiting a CAGR of 6.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Biobanking market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biobanking Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biobanking market in any manner.

Global Biobanking Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech Ltd

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Market Segmentation (by Type)

Equipment

Consumable

Biobanking

Market Segmentation (by Application)

Life Sciences

Materials Science

Semiconductors

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Biobanking Market

Overview of the regional outlook of the Biobanking Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biobanking
1.2 Key Market Segments
1.2.1 Biobanking Segment by Type
1.2.2 Biobanking Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biobanking Market Overview
2.1 Global Market Overview
2.1.1 Global Biobanking Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biobanking Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biobanking Market Competitive Landscape
3.1 Global Biobanking Sales by Manufacturers (2018-2023)
3.2 Global Biobanking Revenue Market Share by Manufacturers (2018-2023)
3.3 Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biobanking Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biobanking Sales Sites, Area Served, Product Type
3.6 Biobanking Market Competitive Situation and Trends
3.6.1 Biobanking Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biobanking Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biobanking Industry Chain Analysis
4.1 Biobanking Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biobanking Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biobanking Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biobanking Sales Market Share by Type (2018-2023)
6.3 Global Biobanking Market Size Market Share by Type (2018-2023)
6.4 Global Biobanking Price by Type (2018-2023)
7 Biobanking Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biobanking Market Sales by Application (2018-2023)
7.3 Global Biobanking Market Size (M USD) by Application (2018-2023)
7.4 Global Biobanking Sales Growth Rate by Application (2018-2023)
8 Biobanking Market Segmentation by Region
8.1 Global Biobanking Sales by Region
8.1.1 Global Biobanking Sales by Region
8.1.2 Global Biobanking Sales Market Share by Region
8.2 North America
8.2.1 North America Biobanking Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biobanking Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biobanking Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biobanking Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biobanking Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher
9.1.1 Thermo Fisher Biobanking Basic Information
9.1.2 Thermo Fisher Biobanking Product Overview
9.1.3 Thermo Fisher Biobanking Product Market Performance
9.1.4 Thermo Fisher Business Overview
9.1.5 Thermo Fisher Biobanking SWOT Analysis
9.1.6 Thermo Fisher Recent Developments
9.2 Beckman Coulter
9.2.1 Beckman Coulter Biobanking Basic Information
9.2.2 Beckman Coulter Biobanking Product Overview
9.2.3 Beckman Coulter Biobanking Product Market Performance
9.2.4 Beckman Coulter Business Overview
9.2.5 Beckman Coulter Biobanking SWOT Analysis
9.2.6 Beckman Coulter Recent Developments
9.3 Panasonic
9.3.1 Panasonic Biobanking Basic Information
9.3.2 Panasonic Biobanking Product Overview
9.3.3 Panasonic Biobanking Product Market Performance
9.3.4 Panasonic Business Overview
9.3.5 Panasonic Biobanking SWOT Analysis
9.3.6 Panasonic Recent Developments
9.4 SOL Group
9.4.1 SOL Group Biobanking Basic Information
9.4.2 SOL Group Biobanking Product Overview
9.4.3 SOL Group Biobanking Product Market Performance
9.4.4 SOL Group Business Overview
9.4.5 SOL Group Biobanking SWOT Analysis
9.4.6 SOL Group Recent Developments
9.5 Promega
9.5.1 Promega Biobanking Basic Information
9.5.2 Promega Biobanking Product Overview
9.5.3 Promega Biobanking Product Market Performance
9.5.4 Promega Business Overview
9.5.5 Promega Biobanking SWOT Analysis
9.5.6 Promega Recent Developments
9.6 Merck
9.6.1 Merck Biobanking Basic Information
9.6.2 Merck Biobanking Product Overview
9.6.3 Merck Biobanking Product Market Performance
9.6.4 Merck Business Overview
9.6.5 Merck Recent Developments
9.7 Greiner Bio One
9.7.1 Greiner Bio One Biobanking Basic Information
9.7.2 Greiner Bio One Biobanking Product Overview
9.7.3 Greiner Bio One Biobanking Product Market Performance
9.7.4 Greiner Bio One Business Overview
9.7.5 Greiner Bio One Recent Developments
9.8 Chart Industries
9.8.1 Chart Industries Biobanking Basic Information
9.8.2 Chart Industries Biobanking Product Overview
9.8.3 Chart Industries Biobanking Product Market Performance
9.8.4 Chart Industries Business Overview
9.8.5 Chart Industries Recent Developments
9.9 Brooks Life Science
9.9.1 Brooks Life Science Biobanking Basic Information
9.9.2 Brooks Life Science Biobanking Product Overview
9.9.3 Brooks Life Science Biobanking Product Market Performance
9.9.4 Brooks Life Science Business Overview
9.9.5 Brooks Life Science Recent Developments
9.10 Tecan Group
9.10.1 Tecan Group Biobanking Basic Information
9.10.2 Tecan Group Biobanking Product Overview
9.10.3 Tecan Group Biobanking Product Market Performance
9.10.4 Tecan Group Business Overview
9.10.5 Tecan Group Recent Developments
9.11 QIAGEN
9.11.1 QIAGEN Biobanking Basic Information
9.11.2 QIAGEN Biobanking Product Overview
9.11.3 QIAGEN Biobanking Product Market Performance
9.11.4 QIAGEN Business Overview
9.11.5 QIAGEN Recent Developments
9.12 BD
9.12.1 BD Biobanking Basic Information
9.12.2 BD Biobanking Product Overview
9.12.3 BD Biobanking Product Market Performance
9.12.4 BD Business Overview
9.12.5 BD Recent Developments
9.13 Lifeline Scientific
9.13.1 Lifeline Scientific Biobanking Basic Information
9.13.2 Lifeline Scientific Biobanking Product Overview
9.13.3 Lifeline Scientific Biobanking Product Market Performance
9.13.4 Lifeline Scientific Business Overview
9.13.5 Lifeline Scientific Recent Developments
9.14 Hamilton
9.14.1 Hamilton Biobanking Basic Information
9.14.2 Hamilton Biobanking Product Overview
9.14.3 Hamilton Biobanking Product Market Performance
9.14.4 Hamilton Business Overview
9.14.5 Hamilton Recent Developments
9.15 So-Low
9.15.1 So-Low Biobanking Basic Information
9.15.2 So-Low Biobanking Product Overview
9.15.3 So-Low Biobanking Product Market Performance
9.15.4 So-Low Business Overview
9.15.5 So-Low Recent Developments
9.16 TTP Labtech Ltd
9.16.1 TTP Labtech Ltd Biobanking Basic Information
9.16.2 TTP Labtech Ltd Biobanking Product Overview
9.16.3 TTP Labtech Ltd Biobanking Product Market Performance
9.16.4 TTP Labtech Ltd Business Overview
9.16.5 TTP Labtech Ltd Recent Developments
9.17 Biolife Solutions
9.17.1 Biolife Solutions Biobanking Basic Information
9.17.2 Biolife Solutions Biobanking Product Overview
9.17.3 Biolife Solutions Biobanking Product Market Performance
9.17.4 Biolife Solutions Business Overview
9.17.5 Biolife Solutions Recent Developments
9.18 DNA Genotek
9.18.1 DNA Genotek Biobanking Basic Information
9.18.2 DNA Genotek Biobanking Product Overview
9.18.3 DNA Genotek Biobanking Product Market Performance
9.18.4 DNA Genotek Business Overview
9.18.5 DNA Genotek Recent Developments
9.19 Custom Biogenic Systems
9.19.1 Custom Biogenic Systems Biobanking Basic Information
9.19.2 Custom Biogenic Systems Biobanking Product Overview
9.19.3 Custom Biogenic Systems Biobanking Product Market Performance
9.19.4 Custom Biogenic Systems Business Overview
9.19.5 Custom Biogenic Systems Recent Developments
9.20 LVL Technologies
9.20.1 LVL Technologies Biobanking Basic Information
9.20.2 LVL Technologies Biobanking Product Overview
9.20.3 LVL Technologies Biobanking Product Market Performance
9.20.4 LVL Technologies Business Overview
9.20.5 LVL Technologies Recent Developments
9.21 BioRep
9.21.1 BioRep Biobanking Basic Information
9.21.2 BioRep Biobanking Product Overview
9.21.3 BioRep Biobanking Product Market Performance
9.21.4 BioRep Business Overview
9.21.5 BioRep Recent Developments
10 Biobanking Market Forecast by Region
10.1 Global Biobanking Market Size Forecast
10.2 Global Biobanking Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biobanking Market Size Forecast by Country
10.2.3 Asia Pacific Biobanking Market Size Forecast by Region
10.2.4 South America Biobanking Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biobanking by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Biobanking Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biobanking by Type (2024-2029)
11.1.2 Global Biobanking Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biobanking by Type (2024-2029)
11.2 Global Biobanking Market Forecast by Application (2024-2029)
11.2.1 Global Biobanking Sales (K Units) Forecast by Application
11.2.2 Global Biobanking Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings